Table 4 Autologous transplantation with plerixafor mobilized PBSCs

From: Plerixafor plus granulocyte CSF can mobilize hematopoietic stem cells from multiple myeloma and lymphoma patients failing previous mobilization attempts: EU compassionate use data

  Myeloma Lymphoma All cases
Patients transplanted N (%) 19 (59) 16 (67) 35 (63)
CD34+ cells infused ( × 10 6 per kg)
 Median 2.9 2.5 2.8
 Min–Max 2.1–7.7 1.9–4.6 1.9–7.7
 Mean (s.d.) 3.5 (1.4) 2.8 (0.8) 3.1 (1.2)
Patients not transplanted N (%) 13 (41) 8 (33) 21 (37)
Cause for not undergoing auto-SCT
 Waiting list 8 (62) 2 (25) 10 (48)
 Mobilization failure 3 (23) 2 (25) 5 (24)
 ‘Rainy-day’ collection 3 (38) 3 (14)
 Disease progression 1 (8) 1 (8) 2 (10)
 Poor organ function 1 (8) 1 (5)